| Literature DB >> 26392288 |
A S Grumach1, C Stieber2,3, C L Veronez4, N Cagini4, R N Constantino-Silva1, E Cordeiro1, M M Nöthen2,3, J B Pesquero4, S Cichon2,3,5.
Abstract
Hereditary angio-oedema (HAE) with normal C1 inhibitor is associated with heterozygous mutations in the factor XII gene (FXII-HAE). We report two Brazilian FXII-HAE families segregating the mutation c.983 C>A (p.Thr328Lys). In each family, one patient with a homozygous mutation was found. The homozygous female patient in family 1 displayed a severe phenotype. However, this falls within the clinical phenotype spectrum reported for heterozygous female mutation carriers. The homozygous male patient in family 2 also showed a severe phenotype. This finding is intriguing, as to our knowledge, it is the first such report for a male FXII-HAE mutation carrier. In the rare instances in which male mutation carriers are affected, a mild phenotype is typical. The present findings therefore suggest that homozygous FXII-HAE mutation status leads to a severe phenotype in females and males, and to an increased risk of manifest symptoms in the latter.Entities:
Keywords: factor XII; hereditary angio-oedema; homozygosity
Mesh:
Substances:
Year: 2015 PMID: 26392288 DOI: 10.1111/all.12769
Source DB: PubMed Journal: Allergy ISSN: 0105-4538 Impact factor: 13.146